Showing results (1441-1450 of 1,714) with videos related to
Sort By:
Pageof 172
Molecular Cancer Therapeutics|May 16, 2012
SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activitiesAntoine Alam, Isabelle Blanc, Geneviève Gueguen-Dorbes, et al.JACC. Cardiovascular Interventions|February 22, 2020
Pathology and Multimodality Imaging of Acute and Chronic Femoral Stenting in HumansSalomé H Kuntz, Sho Torii, Hiroyuki Jinnouchi, et al.The Journal of Hospital Infection|December 21, 2006
Reduced fungal contamination of the indoor environment with the Plasmair system (Airinspace)N Sixt, F Dalle, I Lafon, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|June 23, 2017
The aggressor at the mirror: Psychiatric correlates of deliberate self-harm in male prison inmatesN Verdolini, A Murru, L Attademo, et al.Annals of Neurology|July 29, 2011
Systemic inflammation disrupts the developmental program of white matterGéraldine Favrais, Yohan van de Looij, Bobbi Fleiss, et al.Journal of Affective Disorders|March 19, 2013
Validity and reliability of a rating scale on subjective cognitive deficits in bipolar disorder (COBRA)Adriane R Rosa, Clara Mercadé, Jose Sánchez-Moreno, et al.The Journal of Antimicrobial Chemotherapy|October 16, 2019
Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coliÁngel Rodríguez-Villodres, María Luisa Gil-Marqués, Rocío Álvarez-Marín, et al.Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|January 31, 2024
Definition of normal, neutral, deviant and aberrant coronal knee alignment for total knee arthroplastyMichael T Hirschmann, Zainab Aqeel Khan, Manuel P Sava, et al.Nutrition (Burbank, Los Angeles County, Calif.)|November 17, 2021
Genetic factors associated with alterations in liver function test results in adult hospitalized patients treated with parenteral nutrition: A substudy of a clinical trialJosep Llop-Talaveron, Elisabet Leiva-Badosa, Pedro Alia-Ramos, et al.Clinical Hematology International|January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective studyNicolas Stocker, Tamim Alsuliman, Elise Corre, et al.Pageof 172